AstraZeneca PLC (LON:AZN)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 12,614
-4 (-0.03%)
Oct 21, 2026, 4:38 PM BST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 195.65 billion as of October 21, 2026. It is the 63rd most valuable company in the world and the 3rd biggest in the United Kingdom. Its market cap has increased by 0.42% in one year.
Market Cap
195.65B
Enterprise Value
216.34B
Revenue
46.25B
Global Rank
Country Rank
#3 United Kingdom
PE Ratio
25.06
ChartMarket Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 195.65B, an increase of 4,199.54%. That is a compound annual growth rate of 11.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 195.65B | -8.51% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 74.55B |
| Haleon | 33.29B |
| Smith & Nephew | 9.06B |
| Convatec Group | 4.63B |
| Hikma Pharmaceuticals | 3.48B |
| Oxford Nanopore Technologies | 2.00B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.50B |